Skip to main content

Table 3 Area under the curve (AUC) in median (IQR), units are mmol/l × 120min except ISR measured in pmol/kg

From: Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease

Variable

Baseline

n

Placebo

n

p

Liraglutide

n

p

Difference

n

p

Glucose

804.3 (735.5; 911.3)

31

− 75.9 (− 143.5; − 29.0)

29

0.0003

− 105.6 (− 213.0; − 40.8)

28

< .0001

− 44.8 (− 122.3; 33.8)

27

0.09

Insulin

36,103 (25,435; 48,380)

30

− 8530 (− 14,630; 1915)

29

0.006

− 11,270 (− 19,382; − 1145)

27

0.002

− 2195 (− 7745; 4250)

27

0.45

ISR

999 (840; 1281)

30

− 205 (− 360; − 32)

29

0.001

− 102 (− 260; 105)

26

0.08

69 (− 25; 247)

25

0.11

NEFA

29.1 (22.6; 37.9)

31

− 2.8 (− 7.5; 2.9)

30

0.06

2.7 (− 5.5; 13.4)

27

0.26

6.5 (− 5.7; 16.9)

27

0.13